Sai Parenterals' subsidiary has renewed a 3-year OTC Medicines Supply Agreement with a leading Australian pharmacy chain.

SP

Sai Parenterals LimitedSAIPARENT · Filed with the exchange

The deal is valued at AUD 30 million, approx Rs. 204 Cr.

No comments yet. Be the first.

More from Sai Parenterals Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.